Medical/Pharmaceuticals
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level
HIGHLIGHTS * Undetectable levels of Prostate Specific Antigen (PSA) have been reported from the first patient with metastatic castrate-resistant prostate cancer (mCRPC) to ever receive two cycles of Clarity's67Cu-SAR-bisPSMA at the 8GBq dose level. PSA is a marker of tumour burden, clinical re...
Innovent's MSCI ESG Rating Upgraded to A
ROCKVILLE, Md. and SUZHOU, China, Nov. 30, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
Scantox acquires QPS Austria's Neuropharmacology Division
EJBY, Denmark, Nov. 30, 2023 /PRNewswire/ -- Today Scantox, together with its majority owner Impilo, has agreed to acquire the neuropharmacology division of QPS Austria GmbH ("QPS Neuro" or "the Company") ultimately owned by QPS Holdings LLC. QPS Neuro is a leading drug discovery Contract Researc...
The Best Class 4 Laser Therapy Machine Takes Center Stage at The 55th Dusseldorf International Hospital and Medical Equipment Exhibition in 2023
DUSSELDORF, Germany, Nov. 30, 2023 /PRNewswire/ -- Rhein Laser Technologies Ltd., a prominent manufacturer specializing in innovative medical lasers for aesthetic and physiotherapy markets with operations inWuhan and Dusseldorf, has garnered widespread acclaim and attention from industry professi...
UroFiber SuperPulsed Thulium Fiber Laser System Officially Debuts at MEDICA 2023
DUSSELDORF, Germany, Nov. 30, 2023 /PRNewswire/ -- UroFiber SuperPulsed Thulium
Fiber Laser System
Peptone and The Institute of Oncology Research (IOR) Bellinzona Announce Collaborative Research Agreement
Collaboration focused on novel target discovery in prostate cancer LONDON and BELLINZONA, Switzerland, Nov. 30, 2023 /PRNewswire/ -- Peptone, a leader in translational biophysics and the design of novel therapeutics against intrinsically disordered proteins (IDPs), and The Institute of Oncology ...
SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D
LINKÖPING, Sweden, Nov. 30, 2023 /PRNewswire/ -- SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D. The expanded agreement between Philips and SyntheticMR means that SyMRI 3D will be included in Philips' global price book once the relevant reg...
Triple Negative Breast Cancer: Expert Consensus on Local Treatment Options
Hong Kong Breast Cancer Foundation Launches "Immunotherapy Drug Financial Assistance Programme" to Benefit Patients in Need HONG KONG, Nov. 30, 2023 /PRNewswire/ -- Breast cancer is the leading cancer facing women inHong Kong. According to the statistics released by the Hong Kong Cancer Registry...
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results
SHANGHAI, Nov. 30, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the third quart...
Philips Future Health Index 2023 Report: Singapore's healthcare sector at the forefront of digital technology adoption to tackle staff shortages and improve efficiency
* 75% of healthcare leaders (vs 56% globally) in Singapore are already using, or planning to use, digital health technology to reduce the impact of healthcare workforce shortages. * A hospital/facility being at the forefront of AI is an important consideration by younger healthcare profession...
Awareness, Accessibility, and Affordability are Crucial for the Early Detection of Thalassemia
- Dr. Zhiyu Peng, Deputy GM at BGI Genomics, Head of the World Hemoglobinopathy Foundation, and Dr.Androulla Eleftheriou, Executive Director at TIF, analyze findings from the Global 2023 State of Thalassemia Awareness Report BANGKOK, Nov. 30, 2023 /PRNewswire/ -- Thalassemia, a hereditary hemogl...
Everest Medicines Announces Acceptance of Nefecon® New Drug Applications for the Treatment of Primary IgA Nephropathy in Adult Patients in South Korea
SHANGHAI, Nov. 30, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that its New Drug Application (NDA) for Nefecon®...
ShiraTronics Announces Groundbreaking Milestone: World's First Trial Phase Procedures for their Chronic Migraine Therapy System in Australian Pilot Study
MINNEAPOLIS, Nov. 30, 2023 /PRNewswire/ -- ShiraTronics, Inc., a pioneering medical device company, today announced the initiation of its groundbreaking RELIEV-CM pilot study inAustralia, marking the world's first seven patients' successful completion of trial phase procedures for their Chronic M...
Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS
MELBOURNE, Australia, Nov. 30, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that the completed Phase II OPALESCENCE investigator-initiated trial (IIT) of its carbonic anhydrase IX (CAIX)-targeting positron emission tomography (PET) imaging candid...
Unither Pharmaceuticals celebrates 30 years of innovation and expertise
PARIS, Nov. 30, 2023 /PRNewswire/ -- Unither Pharmaceuticals, a leading CDMO (Contract Development and Manufacturing Organization), celebrates 30 years in business. In 1993, Unither Pharmaceuticals began operations by acquiring a 17-man pharmaceutical plant that produced 3 pharmaceutical forms. T...
Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort
HIGHLIGHTS * Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67 Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled and treated 3 participants who received therapy with67Cu-SAR-bisPSMA at the highest dose level of 12GBq. * No dose limiting toxicit...
China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device
HAIKOU, China, Nov. 29, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", or the "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that its Dry Eye Disease (DED) therape...
Bahrain, First in the Middle East to Acquire Latest Machine used for Human Genome Sequencing
MANAMA, Bahrain, Nov. 29, 2023 /PRNewswire/ -- The Ministry of Health in the Kingdom ofBahrain has become the first in the Middle East to acquire and inaugurate the use of the cutting-edge NovaSeqTM X Plus machine for human genome sequencing purposes. The move is part of the Kingdom's commitment ...
Ping An Health Wins Good Design Award for Its Innovative Design
SHANGHAI, Nov. 29, 2023 /PRNewswire/ -- Ping An Health was recently honored with
Japan's Good Design Award, commonly known as the "The oriental Oscar Award of
Design", for its outstanding innovation design and user-friendly design.
magAssist Attended 2023 ISMCS to Showcase its Next-Gen Medical Solutions that Improve Treatment Outcomes of Critical Heart Diseases
SUZHOU, China, Nov. 29, 2023 /PRNewswire/ -- Earlier this month, magAssist Co.,Ltd. ("magAssist" and "the Company"), a leading medical developer of extracorporeal life support devices inChina, attended the 29th annual meeting of the International Society for Mechanical Circulatory Support (ISMCS)...
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00Multiple achievements made in China-Hungary BRI conference
[Picked up by 309 media titles]
2024-05-03 06:59Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 280 media titles]
2024-05-03 06:25Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39